PRORADIUM: Prospective multicentre study of prognostic factors in castration resistant prostate cancer (CRPC) patients treated with radium-223

Autor:	Ada M. Medina, R. Lozano Mejorada, U. Ferrandiz Brotons, R. Morales Barrera, E. Gonzalez Billalabeitia, Alejo Rodriguez-Vida, R. García Domínguez, J. Puente, M.A. Gonzalez Del Alba Baamonde, D. Lorente Estelles, J.M. Piulats Rodriguez, M.I. Sáez, D. Olmos Hidalgo, R. Villatoro, P. Borrega García, E. Castro Marcos, Nuria Romero-Laorden, G. De Velasco, O. Fernandez Calvo
Rok vydání:	2017
Předmět:	Radium-223 Oncology Prostate cancer medicine.medical_specialty business.industry Internal medicine medicine Hematology Castration resistant medicine.disease business medicine.drug
Zdroj:	Annals of Oncology. 28:v293-v294
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx370.060
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7e27ad64ba1098935737bb6dcb3d4e93 https://doi.org/10.1093/annonc/mdx370.060 Zobrazit plný text záznamu